Tumors after transplantation: are there associated factors?
Jacobs
U
U
Department of General Internal Medicine, University Hospital, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.
Paar
D
D
Buszello
H
H
Klehr
H U
HU
D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology*; D011183:Postoperative Complications; D012307:Risk Factors; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine